It looks like your are using Internet Explorer.
Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.
To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
Sprint: Prescription DTx - Commercialization Models & Adoption
In the past 2 years a wide variety of companies have co-opted the term “DTx” to describe their digital health offerings. In this meeting we want to focus on a smaller subset of this group: prescription digital therapeutics (PDTs), which are seen as the future of the DTx market. This series of 2 meetings to discuss with other senior leaders the following:
Session 1 (September 1st): Commercialization models
- Even though some PDT companies choose the traditional pharmaceutical pathway (salesforce-based), are Pharma-PDT partnerships the best efficient commercialization model for PDT companies? What are the alternatives?
- New consumer-focused telemedicine approaches to PDT distribution have recently entered the market. What are the pros & cons of this model?
- How does the prescription pathway influence the product pricing?
Session 2 (September 21st): Adoption
- As PDTs are edging closer to becoming incorporated into therapeutic arsenals, the seamless integration into conventional pathways still needs to be ironed out. How can digital health formularies and/or prescription platforms help in PDT adoption?
- In some countries, there is prescription capability (e.g Germany, UK), but current prescription rates are still low. What are the next steps to increase PDT prescription and adoption?
An invite invite link has been sent to you if you do not already have a HealthXL account.
An invite link will be sent to your inbox.
Sprint: Prescription DTx - Commercialization Models & Adoption
Join this HealthXL Event today:
Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.
You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.
Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.
In the past 2 years a wide variety of companies have co-opted the term “DTx” to describe their digital health offerings. In this meeting we want to focus on a smaller subset of this group: prescription digital therapeutics (PDTs), which are seen as the future of the DTx market. This series of 2 meetings to discuss with other senior leaders the following:
Session 1 (September 1st): Commercialization models
- Even though some PDT companies choose the traditional pharmaceutical pathway (salesforce-based), are Pharma-PDT partnerships the best efficient commercialization model for PDT companies? What are the alternatives?
- New consumer-focused telemedicine approaches to PDT distribution have recently entered the market. What are the pros & cons of this model?
- How does the prescription pathway influence the product pricing?
Session 2 (September 21st): Adoption
- As PDTs are edging closer to becoming incorporated into therapeutic arsenals, the seamless integration into conventional pathways still needs to be ironed out. How can digital health formularies and/or prescription platforms help in PDT adoption?
- In some countries, there is prescription capability (e.g Germany, UK), but current prescription rates are still low. What are the next steps to increase PDT prescription and adoption?
Participants
Participants
Lee Shapiro
Managing Partner, 7wireVentures
Michael Pace
CEO & Founder at PalmHealth.co
Gulli Arnason
Chief Marketing & Communications Officer at SidekickHealth
Francesca Wuttke
CEO and Founder, nen Health
Joseph Rubinsztain
CEO & Co-Founder, ChronWell
John Mattison
Operating Partner and CMIO, Arsenal Capital Partners
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Zina Manji
Sr Director of Regulatory Affairs at GSK
Robert Garber
Partner, 7wireVentures
Ashley Mateus
VP Decision Support and Strategic Planning, Akili Interactive
Matt Norton
Vice President of Marketing & Commercial Development at S3 Connected Health
Chris Cera
CEO, Arcweb Technologies
Up to 12
Sprint: Prescription DTx - Commercialization Models & Adoption
In the past 2 years a wide variety of companies have co-opted the term “DTx” to describe their digital health offerings. In this meeting we want to focus on a smaller subset of this group: prescription digital therapeutics (PDTs), which are seen as the future of the DTx market. This series of 2 meetings to discuss with other senior leaders the following:
Session 1 (September 1st): Commercialization models
- Even though some PDT companies choose the traditional pharmaceutical pathway (salesforce-based), are Pharma-PDT partnerships the best efficient commercialization model for PDT companies? What are the alternatives?
- New consumer-focused telemedicine approaches to PDT distribution have recently entered the market. What are the pros & cons of this model?
- How does the prescription pathway influence the product pricing?
Session 2 (September 21st): Adoption
- As PDTs are edging closer to becoming incorporated into therapeutic arsenals, the seamless integration into conventional pathways still needs to be ironed out. How can digital health formularies and/or prescription platforms help in PDT adoption?
- In some countries, there is prescription capability (e.g Germany, UK), but current prescription rates are still low. What are the next steps to increase PDT prescription and adoption?
HealthXL Roundtables
HealthXL community meetings connect senior leaders from around the world.
Our virtual Roundtables are small, participant-led discussions where the HealthXL community discuss digital health challenges and offer solutions.
HealthXL community members lead discussion on a defined topic among a maximum of 12 participants. There is no audience and no recordings, just an interactive space to reflect and share learnings.
At 60-minutes long, roundtables are long enough for meaningful discussion among peers, but short enough to fit into busy schedules.
Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:
- Join any virtual and in-person events
- Invite peers to meetings
- Network
- Gain full access to all articles and HealthXL reports
- Get personalised recommendations
- Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
- Full access to community insights and meeting takeaway reports
HealthXL Masterclasses
HealthXL community events give unparalleled access to digital health leaders from around the world.
Our virtual Masterclasses are 60-minute sessions where a recognised expert in their field provides an in-depth learning experience to a small audience of 8-12 members.
HealthXL Masterclasses give you a chance to join a small group of peers and ask questions of recognised experts in a private, convenient setting.
Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:
- Join any virtual and in-person events
- Invite peers to meetings
- Network
- Gain full access to all articles and HealthXL reports
- Get personalised recommendations
- Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
- Full access to community insights and meeting takeaway reports
HealthXL Webinars
HealthXL community events give unparalleled access to digital health experts from around the world.
Our webinars bring together panels of 3-4 global leaders from the HealthXL community to discuss core trends in digital health.
Gain insights on the latest topics in digital health and ask questions of the expert panel via chat. Webinars run for 60 minutes and recordings are shared with all attendees afterwards.
Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:
- Join any virtual and in-person events
- Invite peers to meetings
- Network
- Gain full access to all articles and HealthXL reports
- Get personalised recommendations
- Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
- Full access to community insights and meeting takeaway reports
Join from anywhere
No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.
The world of Digital Health in one Hub
Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers.
As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.
Our community is growing fast. Don’t miss out on your opportunity to lead the future.
News
Your Digital Health Corner
All Posts
Sprint: Prescription DTx - Commercialization Models & Adoption
Sprint: Prescription DTx - Commercialization Models & Adoption
Sprint: Prescription DTx - Commercialization Models & Adoption
In the past 2 years a wide variety of companies have co-opted the term “DTx” to describe their digital health offerings. In this meeting we want to focus on a smaller subset of this group: prescription digital therapeutics (PDTs), which are seen as the future of the DTx market. This series of 2 meetings to discuss with other senior leaders the following:
Session 1 (September 1st): Commercialization models
- Even though some PDT companies choose the traditional pharmaceutical pathway (salesforce-based), are Pharma-PDT partnerships the best efficient commercialization model for PDT companies? What are the alternatives?
- New consumer-focused telemedicine approaches to PDT distribution have recently entered the market. What are the pros & cons of this model?
- How does the prescription pathway influence the product pricing?
Session 2 (September 21st): Adoption
- As PDTs are edging closer to becoming incorporated into therapeutic arsenals, the seamless integration into conventional pathways still needs to be ironed out. How can digital health formularies and/or prescription platforms help in PDT adoption?
- In some countries, there is prescription capability (e.g Germany, UK), but current prescription rates are still low. What are the next steps to increase PDT prescription and adoption?
Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.
All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.
Frequently asked questions:
What are HealthXL Virtual Meetings?
HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.
How can I connect with other digital health leaders?
HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.
What are the benefits of being a HealthXL community member?
As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.
Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.
